InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,222.68
(
0.16%
)
US TECH 100
17,659.20
(
0.10%
)
Dow Jones
39,512.84
(
0.32%
)
Brent Oil
82.59
(
-1.63%
)
Bitcoin
60,937.56
(
-3.35%
)
Post# of 48316
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

chickpea598

Send PM Follow Ignore
Followers 6
Posts 1400
Boards Moderated 0
Alias Born 08/24/2014

chickpea598

Re: None

Thursday, 03/15/2018 5:52:42 PM

Thursday, March 15, 2018 5:52:42 PM

Post# of 48316
Oncosec pilot TNBC trial was slow to enroll, then trial was expanded by treating 2 heavily pre-treated TNBC patients..now with Opdivo + Oncosec therapy. Both patients had robust response. Either Oncosec got very lucky picking those 2 patients or COMBO works EXCELLENT!
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent ONCSQ News
More ONCSQ News
InvestorsHub NewsWire

Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM

VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM

Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM

Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM

Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM

Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM

Start posting your company's news
Only $200 per official company press release!